Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Activity of GS-9450 in Adults With Non-Alcoholic Steatohepatitis (NASH) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety, tolerability, pharmacokinetics and activity of GS-9450 in adults with nonalcoholic steatohepatitis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• GS-9450

Snippet

Sponsor: Gilead Sciences | Conditions: Nonalcoholic Steatohepatitis | Phase 2 | Status: COMPLETED